CUSIP: G6365B104
What is CUSIP G6365B104?
CUSIP G6365B104 identifies HKPD - Cellyan Biotechnology Co., Ltd - Ordinary Shares, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP G6365B104:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Wang Liying | 65% | $11,511,500 | 7,150,000 | Liying Wang | 06 Oct 2025 | |||
| Wong Lap Sun | 57% | $7,369,054 | 6,244,961 | Lap Sun Wong | 31 Mar 2025 | |||
| Pacific Health Century International Group | 5.6% | $729,063 | 617,850 | Pacific Health Century International Group | 31 Mar 2025 | |||
| Atlantic Health Century International Group | 5.6% | $729,063 | 617,850 | Atlantic Health Century International Group | 31 Mar 2025 |
As of 31 Dec 2025, 4 institutional investors reported holding 73,590 shares of Cellyan Biotechnology Co., Ltd - Ordinary Shares, par value $0.001 per share (HKPD). This represents 0.67% of the company’s total 11,000,000 outstanding shares.